Results 151 to 160 of about 5,403 (175)
Some of the next articles are maybe not open access.
Radioimmunotherapy for Waldenstrom's macroglobulinemia
Seminars in Oncology, 2003Radioimmunotherapy targeting CD20 is a promising novel treatment for lymphoma. Prior trials have established the safe dose of Zevalin ((90)Y-ibritumomab tiuxetan; IDEC Pharmaceuticals) for patients with no more than 25% bone marrow (BM) involvement. Zevalin is expected to be an effective treatment for WM; however, the safe dose has not been defined.
openaire +2 more sources
Harnessing 64 Cu/ 67 Cu for a theranostic approach to pretargeted radioimmunotherapy
Proceedings of the National Academy of Sciences of the United States of America, 2020Ellen Van Dam +2 more
exaly
B7-H3-targeted Radioimmunotherapy of Human Cancer
Current Medicinal Chemistry, 2020Kurt Zinn, Donald Buchsbaum
exaly
Clinical radioimmunotherapy—the role of radiobiology
Nature Reviews Clinical Oncology, 2011Jean-Pierre Pouget +2 more
exaly
Zevalin: the first radioimmunotherapy approved for the treatment of lymphoma
Expert Review of Anticancer Therapy, 2002Antonio J Grillo-Lopez
exaly